BL
WINT

BCWM LLC’s Windtree Therapeutics Inc WINT Stock Holding History

BCWM LLC’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,286
Closed -$332 – 103
2014
Q3 		$332 Buy
1,286
+143
+13% +$3.45K 0.02% 94
2014
Q2 		$29K Buy
+1,143
New +$29.2K 0.01% 89

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

BCWM LLC's WINT Position: Q4 2014 in Review

BCWM LLC sold out of Windtree Therapeutics Inc (WINT) in Q4 2014, closing a stake of 1,286 shares — an estimated $332 sold.

BCWM LLC first reported a position in WINT in Q2 2014 and held it in 2 quarters. The position peaked at $29K in Q2 2014. 56 funds tracked by Wall St. Rank hold WINT as of Q4 2014.

  • BCWM LLC reported no remaining Windtree Therapeutics Inc position as of Q4 2014 after selling out during the quarter.
  • BCWM LLC sold 1,286 Windtree Therapeutics Inc shares in Q4 2014, an estimated $332.
  • BCWM LLC first reported a position in Windtree Therapeutics Inc in Q2 2014 and held it in 2 quarters.
  • BCWM LLC's Windtree Therapeutics Inc position peaked at $29K in Q2 2014.
  • 56 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2014.

Based on BCWM LLC's 13F filing for Q4 2014, filed 13 Feb 2015.